Bayer Kogenate FS Free Trial Program Fails To Include Labeling, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The CBER ad division letter cites the promotional materials for lack of risk information and failure to provide adequate direction for use.
You may also be interested in...
Bayer Kogenate FS Free Trial Launches With Bio-Set Needle Free System
Hemophilia A treatment promotion incorporates risk information after an earlier promotion drew FDA criticism.
Bayer Kogenate FS Free Trial Launches With Bio-Set Needle Free System
Hemophilia A treatment promotion incorporates risk information after an earlier promotion drew FDA criticism.
Bayer Trial Program Offers Six Free Infusions Of Kogenate FS
“The Kogenate FS Experience Program” includes an opportunity for hemophilia A patients in the U.S. to sample support programs and services, in addition to free treatment.